DJ Vertex Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ rallied 1.70% to $511.74 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.76% to 5,767.57 and the Dow Jones Industrial Average rising 1.42% to 42,583.32.
The stock's rise snapped a two-day losing streak.
Vertex Pharmaceuticals Inc. closed 1.57% below its 52-week high of $519.88, which the company achieved on November 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. $(ABBV)$ fell 0.40% to $209.17, Krystal Biotech Inc. (KRYS) rose 3.90% to $194.44, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 3.03% to $13.27.
Trading volume (1.2 M) remained 246,773 below its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 24, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 24, 2025 16:36 ET (20:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.